All Curated Mutation Sites in EBV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in EBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
LMP-1
  
BZLF1
  
EBNA-1
  
EBNA-2
  
EBNA-3A
  
EBNA-3B/EBNA-3C
  
LMP-2A
  
LMP-2
  
EBNA-2
  
BARF1
  
BALF2
  
BXLF1
  
BPLF1
  
BcRF1
  
BFRF2
  
BILF1
  
BLLF1
  
BMRF1
  
BNRF1
  
BOLF1
  
BRRF2
  
LF1
  

Keyword: LMP-2A
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 17657160 S348T
LMP-2A
LMP-2A
Lymphoma, Extranodal NK-T-Cell
L
View
2 29093097 S444T
LMP-2A
LMP-2A
Stomach Neoplasms
R
S
View
3 29093097 Y23D
LMP-2A
LMP-2A
Stomach Neoplasms
R
S
View
4 29093097 S349T
LMP-2A
LMP-2A
Stomach Neoplasms
R
S
View
5 22470549 S15N
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
6 22470549 Y23D
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
7 22470549 T79N
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
8 22470549 Q82P
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
9 22470549 L84L
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
10 22470549 Y112Y
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
11 22470549 L133L
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
12 22470549 F144F
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
13 22470549 V152V
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
14 22470549 T153P
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
15 22470549 T153S
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
16 22470549 L162L
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
17 22470549 A165A
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
18 22470549 S169N
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
19 22470549 Y171S
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
20 22470549 V182V
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
21 22470549 L183L
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
22 22470549 V184V
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
23 22470549 E201E
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
24 22470549 L208I
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
25 22470549 A234A
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
26 22470549 R237T
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
27 22470549 V244L
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
28 22470549 I248M
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
29 22470549 V254L
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
30 22470549 L255V
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
31 22470549 S348T
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
32 22470549 I350V
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
33 22470549 L360L
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
34 22470549 I370T
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
35 22470549 A371A
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
36 22470549 S384S
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
37 22470549 T386S
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
38 22470549 P390P
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
39 22470549 S391R
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
40 22470549 L398L
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
41 22470549 F405F
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
42 22470549 G414G
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
43 22470549 P422P
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
44 22470549 C426S
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
45 22470549 L427L
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
46 22470549 G428G
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
47 22470549 M443V
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
48 22470549 S444T
LMP-2A
LMP-2A
Stomach Neoplasms
R
C
L
View
Contents
Description

The table shows all curated mutation sites of EBV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.